Evaluating Fracture Risk in Patients with Primary Hyperparathyroidism
-
By
-
Robert D. Blank
-
March 19, 2026
By
Robert D. Blank
March 19, 2026
by Robert D. Blank
March 19, 2026
Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.
June 27, 2026
Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.
June 26, 2026
Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.
June 9, 2026